Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Clin Exp Rheumatol. 2009 Sep-Oct;27(5):826-9.
To characterize autoreactive T cells against myeloperoxidase (MPO) by generating antigen-specific T-cell clones from patients with microscopic polyangiitis (MPA) and healthy individuals.
Peripheral blood T cells from five patients with MPA and MPO-anti-neutrophil cytoplasmic antibodies (ANCAs) and from three healthy donors were used to establish MPO-specific T-cell clones by repeated stimulation with recombinant MPO fragments, followed by limiting dilution. The MPO-specific T-cell clones were subjected to analyses for CD4/CD8 phenotype, human leukocyte antigen (HLA) class II restriction, T-cell receptor (TCR) Beta-chain gene usage, complementarity-determining region 3 (CDR3) amino acid sequences, and cytokine expression profiles.
We successfully generated seven MPO-specific T-cell clones, five from the patients and two from healthy donors. Two clones recognized the light chain of MPO and five recognized the heavy chain. All the clones were HLA-DR-restricted CD4(+)CD8(-) helper T cells. The T-cell clones shared TCR Beta CDR3 amino acid motifs, depending on their MPO epitope: AGXiXiN was used by clones recognizing the light chain and TGXiS or QGXiE by those recognizing the heavy chain, whether the cells were derived from MPA patients or healthy subjects. However, the cytokine expression profiles of the patients' clones were skewed towards the Th1 phenotype, whereas the healthy individuals' clones remained Th0.
We have characterized MPO-reactive T cells in detail. This information may be useful for elucidating the mechanism of ANCA production and for developing selective therapeutic strategies for MPO-ANCA-associated vasculitis.
通过从显微镜下多血管炎(MPA)患者和健康个体中生成抗原特异性 T 细胞克隆,来鉴定针对髓过氧化物酶(MPO)的自身反应性 T 细胞。
使用来自五名 MPA 患者和 MPO-抗中性粒细胞胞质抗体(ANCA)以及三名健康供体的外周血 T 细胞,通过与重组 MPO 片段反复刺激,然后进行有限稀释,来建立 MPO 特异性 T 细胞克隆。对 MPO 特异性 T 细胞克隆进行 CD4/CD8 表型、人白细胞抗原(HLA)II 类限制、T 细胞受体(TCR)β链基因使用、互补决定区 3(CDR3)氨基酸序列和细胞因子表达谱分析。
我们成功生成了七个 MPO 特异性 T 细胞克隆,五个来自患者,两个来自健康供体。两个克隆识别 MPO 的轻链,五个克隆识别重链。所有克隆均为 HLA-DR 限制性 CD4(+)CD8(-)辅助 T 细胞。T 细胞克隆共享 TCR Beta CDR3 氨基酸基序,具体取决于其 MPO 表位:识别轻链的克隆使用 AGXiXiN,识别重链的克隆使用 TGXiS 或 QGXiE,无论细胞是来自 MPA 患者还是健康受试者。然而,患者克隆的细胞因子表达谱偏向于 Th1 表型,而健康个体的克隆仍保持 Th0。
我们详细描述了 MPO 反应性 T 细胞。这些信息可能有助于阐明 ANCA 产生的机制,并为 MPO-ANCA 相关血管炎开发选择性治疗策略。